Healthtech Startups

Renalis develops prescription digital therapeutics (PDTs), software applications that deliver evidence-based therapeutic interventions to patients under a clinician's care to prevent or treat medical disorders. The products are developed like pharmaceuticals, undergoing clinical trials and FDA clearance, and are available only by clinician prescription.

1 investor

RenalTracker provides dietitian-designed nutrition management tools and programs for patients with chronic kidney disease to help them avoid dialysis and improve health outcomes. The platform serves kidney patients aged 60+ with science-backed food lists and personalized dietary guidance.

1 investor

Ren BioScience develops small-molecule therapies aimed at preserving organ function, including an oral lead compound for inherited retinal diseases and preclinical programs targeting acute kidney injury and mitochondrial-driven metabolic and autoimmune conditions. Its focus is on protecting cells from irreversible injury across ophthalmic, renal, and metabolic disease areas.

1 investor

Rendever provides immersive virtual reality experiences for senior living residents designed to reduce social isolation and foster meaningful connections. The platform uses VR headsets to enable shared experiences like virtual travel, reminiscence therapy, and social activities tailored for older adults with cognitive or mobility challenges.

1 investor

Renegade Brands develops proprietary cleaning chemistry for specialized markets, including laundry detergents for athletic wear and products for the healthcare and hospitality industries. The company applies scientific methodology to product development and testing.

1 investor

ReNerve develops nerve repair products, including cuffs, grafts, and bionic nerve structures, to treat transected nerves and improve patient outcomes. The company operates research laboratories in Melbourne, Australia, and collaborates with researchers at the CSIRO / Monash University biomaterials precinct.

1 investor

Renova Therapeutics develops investigational gene therapies intended as single-dose, long-lasting treatments for common chronic diseases, with an initial focus on congestive heart failure and type 2 diabetes. The company builds a platform of therapeutics and delivery systems based on proprietary insights into disease mechanisms.

1 investor

Renovion develops ARINA-1, a next-generation mucolytic therapy delivered as a sterile buffered ascorbic acid and glutathione solution to the lungs. The therapy targets chronic inflammatory airway diseases affecting over 170 million patients globally, including non-cystic fibrosis bronchiectasis, chronic bronchitis, COPD, and asthma.

1 investor

1 investor

RenovoRx develops targeted oncology therapies and commercializes the RenovoCath, an FDA-cleared drug-delivery device for intra-arterial chemotherapy administration in cancer treatment. The company is conducting Phase III clinical trials of its proprietary TAMP therapy platform for treating locally advanced pancreatic cancer with improved safety and efficacy compared to systemic chemotherapy.

1 investor

Renovo Solutions operates a Life Sciences business line providing services and solutions to pharmaceutical, biotech, medical device, and laboratory services companies.

1 investor

RenovoDerm is a life sciences company developing wound care and tissue technology platforms within the medtech and biotech sectors. It operates as a commercial subsidiary of Paragen Technologies.

1 investor

Reopia develops advanced optical solutions that prevent the onset and progression of myopia in children. The company addresses the growing global epidemic of nearsightedness through medical devices targeting pediatric eye health.

1 investor

Replenish manufactures blended beverage systems that prepare plant-based smoothie recipes in seconds using proprietary Hydroblend technology, serving health-conscious consumers who seek convenient nutrition without ingredient shopping or preparation.

1 investor

RepOne provides strength training software and hardware integration tools that enable coaches and athletes to automate workout programming and real-time performance tracking at an affordable cost. The platform targets amateur athletes, professional coaches, and fitness enthusiasts across all experience levels.

1 investor

reprai builds AI agents for pharmaceutical commercial, medical, and market access teams, covering HCP market segmentation, cross-channel engagement, meeting insight capture, rep training simulations, and AI twins of executives and KOLs. Its product suite (reMarket, reFlect, reRep, reTwin, reTrain) automates and optimizes pharma company operations while keeping interactions compliant.

1 investor

REPROSENT captures patient treatment experience data to support dose, safety, and development decisions in oncology and advanced cancer therapies. The platform operates as a lightweight, non-interventional overlay on existing clinical trials and care programs, converting patient symptoms into structured, computable signal for development and clinical teams.

1 investor

ReSchedule Med provides scheduling management software for medical residency programs, addressing the complex logistics involved in coordinating resident assignments and rotations.

1 investor

Rescripted is a digital health platform for women's health covering fertility, pregnancy, menstrual health, sexual health, and chronic condition management, featuring AI-powered health guidance reviewed by medical experts.

1 investor

Rescription operates a pharmacy benefit management company that uses patented technology to deliver transparent, real-time prescription pricing with aligned financial incentives. The company serves self-funded employers, health systems, PBMs, and their members across the United States by applying cost savings at the point of prescription filling rather than through delayed rebate reconciliation.

1 investor

Rescue Swag manufactures durable, comprehensive first aid kits designed for Australian environments, sold with 100% of profits supporting the Royal Flying Doctor Service, a national charitable aeromedical organization.

1 investor

Everlife-Research Instruments supplies research tools, laboratory equipment, and analytical solutions to the scientific and clinical community in Asia. The company provides a full range of services from product distribution to technical support, regulatory guidance, and laboratory design.

1 investor

Reservoir Neuroscience is developing therapeutics aimed at repairing the blood-brain barrier. The company operates in the neuroscience drug development space.

1 investor

ResetSmile provides at-home tooth replacement solutions using a patented system that allows patients to replace missing teeth without visiting a dental office. The company serves the approximately 140 million Americans who have been underserved by traditional dental care options.

1 investor